OMEPRAZOLE, SODIUM BICARBONATE and GASTROOESOPHAGEAL REFLUX DISEASE

45 reports of this reaction

2.1% of all OMEPRAZOLE, SODIUM BICARBONATE reports

#7 most reported adverse reaction

Overview

GASTROOESOPHAGEAL REFLUX DISEASE is the #7 most commonly reported adverse reaction for OMEPRAZOLE, SODIUM BICARBONATE, manufactured by CVS Pharmacy. There are 45 FDA adverse event reports linking OMEPRAZOLE, SODIUM BICARBONATE to GASTROOESOPHAGEAL REFLUX DISEASE. This represents approximately 2.1% of all 2,134 adverse event reports for this drug.

Patients taking OMEPRAZOLE, SODIUM BICARBONATE who experience gastrooesophageal reflux disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

GASTROOESOPHAGEAL REFLUX DISEASE45 of 2,134 reports

GASTROOESOPHAGEAL REFLUX DISEASE is a less commonly reported adverse event for OMEPRAZOLE, SODIUM BICARBONATE, but still significant enough to appear in the safety profile.

Other Side Effects of OMEPRAZOLE, SODIUM BICARBONATE

In addition to gastrooesophageal reflux disease, the following adverse reactions have been reported for OMEPRAZOLE, SODIUM BICARBONATE:

Other Drugs Associated with GASTROOESOPHAGEAL REFLUX DISEASE

The following drugs have also been linked to gastrooesophageal reflux disease in FDA adverse event reports:

ACLIDINIUM BROMIDEACYCLOVIR SODIUMALUMINUM HYDROXIDE AND MAGNESIUM CARBONATEBISMUTH SUBSALICYLATEBOTULINUM TOXIN TYPE ABUFFERED ASPIRINCALCIUM CARBONATE, MAGNESIUM HYDROXIDECIMETIDINEDEXLANSOPRAZOLEDEXPANTHENOLESOMEPRAZOLE MAGNESIUMFAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDEFORMOTEROL FUMARATEGLYCOPYRROLATELIOTHYRONINE SODIUMLOPERAMIDE HYDROCHLORIDE AND SIMETHICONEMAGNESIUM CITRATEMOMETASONEMOMETASONE FUROATENIACINAMIDE

Frequently Asked Questions

Does OMEPRAZOLE, SODIUM BICARBONATE cause GASTROOESOPHAGEAL REFLUX DISEASE?

GASTROOESOPHAGEAL REFLUX DISEASE has been reported as an adverse event in 45 FDA reports for OMEPRAZOLE, SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is GASTROOESOPHAGEAL REFLUX DISEASE with OMEPRAZOLE, SODIUM BICARBONATE?

GASTROOESOPHAGEAL REFLUX DISEASE accounts for approximately 2.1% of all adverse event reports for OMEPRAZOLE, SODIUM BICARBONATE, making it a notable side effect.

What should I do if I experience GASTROOESOPHAGEAL REFLUX DISEASE while taking OMEPRAZOLE, SODIUM BICARBONATE?

If you experience gastrooesophageal reflux disease while taking OMEPRAZOLE, SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

OMEPRAZOLE, SODIUM BICARBONATE Full ProfileAll Drugs Causing GASTROOESOPHAGEAL REFLUX DISEASECVS Pharmacy Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.